BioSpace News Archive

Business

Charles River and Takeda Enter Multi-Year Drug Discovery Deal

Charles River will use its strengths to help develop potential drug candidates across Takeda’s four core therapeutic areas—oncology, gastroenterology, neuroscience and rare disease.

January 14, 2020
·
2 min read
·
Alex Keown
Drug Development

AbbVie’s Skyrizi Beats Out Novartis’ Cosentyx in Plaque Psoriasis

AbbVie reported that its Skyrizi met both primary and all ranked secondary endpoints in its Phase III trial that went head-to-head with Novartis’ Cosentyx in plaque psoriasis.

January 14, 2020
·
3 min read
·
Mark Terry
FDA

GSK’s CEO Predicts Six Drug Approvals for the Company in 2020

Emma Walmsley, chief executive officer of GlaxoSmithKline, is predicting a good year for her company, with the potential of six regulatory approvals in the United States.

January 14, 2020
·
3 min read
·
Alex Keown
Business

Gilead Backs Startup Kyverna Therapeutics with Financing, Collaborative Agreement

Gilead Sciences is boosting support for a Bay Area startup looking to develop a new class of therapies for autoimmune diseases.

January 14, 2020
·
2 min read
·
Alex Keown
sphingotec Transforms Into End-to-end Diagnostic Solutions Provider and Exclusively Represents Nexus Dx IB10 Immunoassay Portfolio

Following the acquisition and integration of former Samsung subsidiary Nexus Dx Inc., sphingotec becomes a fully integrated diagnostic solutions provider

January 14, 2020
·
7 min read
Business

After Abandoning PacBio Deal, Illumina Inks 15-Year Pact with Roche

The deal will increase the availability of next-generation sequencing-based in vitro diagnostic (IVD) tests on Illumina’s diagnostic sequencing systems.

January 14, 2020
·
2 min read
·
Mark Terry
Career Advice

Jump-Starting Your 2020 Job Search

While early January can still be a slow time for hiring as people get organized, once the middle of the month hits, it’s go time.

January 14, 2020
·
2 min read
·
Laura Brothers
Bio NC

With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans

With the 2020 elections looming though, and lawmakers across the country drafting legislation aimed at curbing price increases, some companies are carefully examining the landscape as they approach pricing.

January 14, 2020
·
3 min read
·
Alex Keown
Business

Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery

Exscientia, the leading Artificial Intelligence -driven drug discovery company, announced today that it has entered a collaboration with Bayer AG that aims to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.

January 14, 2020
·
2 min read
Genetown

TGaS Kicks Off 2020 with New Hire, Promotions

TGaS® Advisors, a division of TRINITY, announced a new hire and several promotions at the life sciences benchmarking and advisory services firm.

January 14, 2020
·
2 min read